Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement S. Otero-Romero; J. Rodríguez-García; A. Vilella; J.R. Ara; L. Brieva; C. Calles; O. Carmona; V. Casanova; L. Costa-Frossard; S. Eichau; J.A. García-Merino; C. Garcia-Vidal; M. González-Platas; M. Llaneza; M. Martínez-Ginés; J.E. Meca-Lallana; J.M. Prieto; A. Rodríguez-Antigüedad; M. Tintoré; Y. Blanco; E. Moral;

Incidence and prevalence of multiple sclerosis in Spain: a systematic review F.J. García López; A. García-Merino; E. Alcalde-Cabero; J. de Pedro-Cuesta;

Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study J.E. Meca-Lallana; J.C. Álvarez-Cermeño; B. Casanova Estruch; G. Izquierdo Ayuso; R. Ortiz Castillo; A. Rodríguez-Antigüedad; C. Calles Hernández;